BRPI0821046A2 - hidrogel coesivo monofásico biodegradável, processo de preparação do mesmo, utilização de um hidrogel, e, kit - Google Patents

hidrogel coesivo monofásico biodegradável, processo de preparação do mesmo, utilização de um hidrogel, e, kit

Info

Publication number: BRPI0821046A2
Authority: BR; Brazil
Prior art keywords: hydrogel; kit; preparation process; single phase; biodegradable single
Prior art date: 2007-12-07

Application number

BRPI0821046A

Other languages

English (en)

Inventor

Guy Vitally

Marie Estelle Piron

Original Assignee

Vivacy Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-12-07

Filing date

2008-12-08

Publication date

2015-09-22

2008-12-08 Application filed by Vivacy Lab filed Critical Vivacy Lab

2015-09-22 Publication of BRPI0821046A2 publication Critical patent/BRPI0821046A2/pt

2017-04-04 Publication of BRPI0821046B1 publication Critical patent/BRPI0821046B1/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/26—Mixtures of macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/738—Cross-linked polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/733—Alginic acid; Salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/594—Mixtures of polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Birds (AREA)
Dermatology (AREA)
Pharmacology & Pharmacy (AREA)
Transplantation (AREA)
Oral & Maxillofacial Surgery (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Dispersion Chemistry (AREA)
Gerontology & Geriatric Medicine (AREA)
Molecular Biology (AREA)
Toxicology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Immunology (AREA)
Ophthalmology & Optometry (AREA)
Surgery (AREA)
Urology & Nephrology (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Compositions Of Macromolecular Compounds (AREA)
Polymers & Plastics (AREA)
Prostheses (AREA)
Processes Of Treating Macromolecular Substances (AREA)

BRPI0821046A 2007-12-07 2008-12-08 hidrogel coesivo monofásico biodegradável, processo de preparação do mesmo, utilização de um hidrogel, e, kit BRPI0821046B1 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0759641A FR2924615B1 (fr)	2007-12-07	2007-12-07	Hydrogel cohesif biodegradable.
PCT/EP2008/067029 WO2009071697A1 (fr)	2007-12-07	2008-12-08	Hydrogel cohésif monophasique biodégradable

Publications (2)

Publication Number	Publication Date
BRPI0821046A2 true BRPI0821046A2 (pt)	2015-09-22
BRPI0821046B1 BRPI0821046B1 (pt)	2017-04-04

Family

ID=39473297

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0821046A BRPI0821046B1 (pt)	2007-12-07	2008-12-08	hidrogel coesivo monofásico biodegradável, processo de preparação do mesmo, utilização de um hidrogel, e, kit

Country Status (17)

Country	Link
US (6)	US20100303873A1 (pt)
EP (2)	EP2572702B1 (pt)
JP (2)	JP5571562B2 (pt)
KR (1)	KR101597333B1 (pt)
CN (1)	CN101925348B (pt)
AU (1)	AU2008333132B2 (pt)
BR (1)	BRPI0821046B1 (pt)
CA (1)	CA2708023C (pt)
EA (1)	EA022478B1 (pt)
ES (2)	ES2538999T3 (pt)
FR (1)	FR2924615B1 (pt)
IL (1)	IL206166A (pt)
MX (1)	MX2010006248A (pt)
PL (2)	PL2231108T3 (pt)
PT (2)	PT2231108E (pt)
UA (1)	UA99161C2 (pt)
WO (1)	WO2009071697A1 (pt)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2861734B1 (fr)	2003-04-10	2006-04-14	Corneal Ind	Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
AU2008256819A1 (en)	2007-05-23	2008-12-04	Allergan, Inc.	Cross-linked collagen and uses thereof
US8318695B2 (en)	2007-07-30	2012-11-27	Allergan, Inc.	Tunably crosslinked polysaccharide compositions
US8697044B2 (en)	2007-10-09	2014-04-15	Allergan, Inc.	Crossed-linked hyaluronic acid and collagen and uses thereof
MX2010005331A (es)	2007-11-16	2010-08-11	Vicept Therapeutics Inc	Composiciones y metodos para tratamiento de purpura.
US8394784B2 (en)	2007-11-30	2013-03-12	Allergan, Inc.	Polysaccharide gel formulation having multi-stage bioactive agent delivery
US8394782B2 (en)	2007-11-30	2013-03-12	Allergan, Inc.	Polysaccharide gel formulation having increased longevity
US8357795B2 (en)	2008-08-04	2013-01-22	Allergan, Inc.	Hyaluronic acid-based gels including lidocaine
WO2010028025A1 (en)	2008-09-02	2010-03-11	Gurtner Geoffrey C	Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
FR2938187B1 (fr)	2008-11-07	2012-08-17	Anteis Sa	Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur
IT1395392B1 (it) *	2009-08-27	2012-09-14	Fidia Farmaceutici	Geli viscoelastici come nuovi filler
US20110172180A1 (en)	2010-01-13	2011-07-14	Allergan Industrie. Sas	Heat stable hyaluronic acid compositions for dermatological use
US9114188B2 (en)	2010-01-13	2015-08-25	Allergan, Industrie, S.A.S.	Stable hydrogel compositions including additives
AU2010348090B2 (en)	2010-03-12	2015-09-03	Allergan Industrie Sas	A fluid composition comprising a hyaluronan polymer and mannitol for improving skin condition
EP2550027B2 (en)	2010-03-22	2019-03-20	Allergan, Inc.	Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
US9005605B2 (en)	2010-08-19	2015-04-14	Allergan, Inc.	Compositions and soft tissue replacement methods
US8889123B2 (en)	2010-08-19	2014-11-18	Allergan, Inc.	Compositions and soft tissue replacement methods
EP2605746A2 (en) *	2010-08-19	2013-06-26	Merz Pharma GmbH & Co. KGaA	Filler composition comprising beta-glucans
US8883139B2 (en)	2010-08-19	2014-11-11	Allergan Inc.	Compositions and soft tissue replacement methods
US8697057B2 (en)	2010-08-19	2014-04-15	Allergan, Inc.	Compositions and soft tissue replacement methods
FR2968305B1 (fr) *	2010-12-06	2014-02-28	Teoxane	Procede de preparation d'un gel reticule
CA3038735C (en)	2011-06-03	2021-11-23	Allergan, Inc.	Dermal filler compositions including antioxidants
US9408797B2 (en)	2011-06-03	2016-08-09	Allergan, Inc.	Dermal filler compositions for fine line treatment
US9393263B2 (en)	2011-06-03	2016-07-19	Allergan, Inc.	Dermal filler compositions including antioxidants
US20130096081A1 (en)	2011-06-03	2013-04-18	Allergan, Inc.	Dermal filler compositions
US9662422B2 (en)	2011-09-06	2017-05-30	Allergan, Inc.	Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en)	2011-09-06	2013-09-19	Allergan, Inc.	Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
FR2991876B1 (fr)	2012-06-13	2014-11-21	Vivacy Lab	Composition, en milieu aqueux, comprenant au moins un acide hyaluronique et au moins un sel hydrosoluble de sucrose octasulfate
AR091454A1 (es)	2012-06-15	2015-02-04	Merz Pharma Gmbh & Co Kgaa	Metodo para preparar una composicion a base de acido hialuronico
KR101421933B1 (ko) *	2012-06-19	2014-07-28	서울과학기술대학교 산학협력단	생분해성 하이브리드 하이드로젤 및 그 제조방법
FR2994846B1 (fr)	2012-08-29	2014-12-26	Vivacy Lab	Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium
WO2014198406A1 (en)	2013-06-11	2014-12-18	Anteis S.A.	Method for crosslinking hyaluronic acid; method for preparing an injectable hydrogel; hydrogel obtained; use of the obtained hydrogel
FR3006689A1 (fr)	2013-06-11	2014-12-12	Benedicte Vincente Tauzin	Procede de reticulation de l'acide hyaluronique; procede de preparation d'un hydrogel injectable; hydrogel obtenu; utilisation de l'hydroget obtenu
US9387151B2 (en)	2013-08-20	2016-07-12	Anutra Medical, Inc.	Syringe fill system and method
US9155757B2 (en)	2013-10-07	2015-10-13	Laboratoires Vivacy	Methods and kits for treating vaginal and vulvar vestibule mucosa disorders
FR3015290B1 (fr)	2013-12-23	2017-01-13	Lab Vivacy	Compositions d'acide hyaluronique compreant de la mepivacaine
AR099900A1 (es)	2014-04-01	2016-08-24	Merz Pharma Gmbh & Co Kgaa	Rellenos para tejidos blandos con polisacáridos con persistencia mejorada, kit, procedimiento, uso
USD774182S1 (en)	2014-06-06	2016-12-13	Anutra Medical, Inc.	Anesthetic delivery device
USD763433S1 (en)	2014-06-06	2016-08-09	Anutra Medical, Inc.	Delivery system cassette
USD750768S1 (en)	2014-06-06	2016-03-01	Anutra Medical, Inc.	Fluid administration syringe
CN104086788B (zh) *	2014-07-17	2016-08-17	华熙福瑞达生物医药有限公司	一种注射用修饰透明质酸钠凝胶
ES2761558T3 (es)	2014-09-30	2020-05-20	Allergan Ind Sas	Composiciones de hidrogel estables que incluyen aditivos
TWI716365B (zh) *	2014-11-13	2021-01-21	德商梅茲製藥有限兩合公司	注射型真皮填充劑組合物及其套組、製備方法、與使用
EP3040118A1 (en) *	2014-12-29	2016-07-06	Galderma S.A.	Ether cross-linked chondroitin hydrogels and their use for soft tissue applications
EP3040117A1 (en) *	2014-12-29	2016-07-06	Galderma S.A.	Ether cross-linked chondroitin sulfate hydrogels and their use for soft tissue applications
WO2016128783A1 (en)	2015-02-09	2016-08-18	Allergan Industrie Sas	Compositions and methods for improving skin appearance
KR20170118105A (ko)	2015-02-13	2017-10-24	알러간 인더스트리 에스에이에스	턱과 같은 얼굴 이목구비를 조각, 확대 또는 교정하기 위한 임플란트
CN104771331B (zh) *	2015-03-12	2017-12-12	华熙福瑞达生物医药有限公司	一种透明质酸弹性体及其应用
US10004824B2 (en)	2015-05-11	2018-06-26	Laboratoires Vivacy	Compositions comprising at least one polyol and at least one anesthetic
FR3036035B1 (fr)	2015-05-11	2018-10-05	Laboratoires Vivacy	Compositions comprenant au moins un polyol et au moins un anesthesique
FR3037797B1 (fr)	2015-06-24	2018-08-17	Kylane Laboratoires Sa	Procede de preparation d'un hydrogel reticule injectable; hydrogel obtenu; utilisation de l'hydrogel obtenu
FR3044557B1 (fr)	2015-12-07	2017-12-01	Benedicte Vincente Gavard Molliard Tauzin	Nouvelle composition injectable; procede de preparation de ladite composition; utilisation de ladite composition
WO2017102001A1 (fr)	2015-12-16	2017-06-22	Vplus International Sa	Composition d'acide hyaluronique pour injections peniennes
CA3013477A1 (en)	2016-02-12	2017-08-17	Rodan & Fields, Llc	Moisturizing compositions and uses thereof
US10722443B2 (en)	2016-09-14	2020-07-28	Rodan & Fields, Llc	Moisturizing compositions and uses thereof
FR3047666A1 (fr)	2016-02-15	2017-08-18	Benedicte Vincente Gavard Molliard Tauzin	Composition injectable; procede de preparation de ladite composition; utilisation de ladite composition
KR101710639B1 (ko) *	2016-06-07	2017-03-08	주식회사 파마리서치프로덕트	핵산, 키토산 및 히알루론산을 포함하는 조직 증강용 충전 조성물 및 이의 제조방법
US10018133B2 (en)	2016-09-22	2018-07-10	Ford Global Technologies, Llc	System and method to extend operating time of valve actuators of an internal combustion engine
FR3058064B1 (fr)	2016-10-28	2020-08-07	Lab Vivacy	Composition a base d'acide hyaluronique comprenant de la mepivacaine
JP6939607B2 (ja) *	2017-03-27	2021-09-22	Jsr株式会社	組成物およびその用途
CN108250462A (zh) *	2017-05-08	2018-07-06	上海利康瑞生物工程有限公司	一种抗酶解交联透明质酸钠凝胶及其制备方法和制剂
WO2018220283A1 (fr)	2017-05-29	2018-12-06	Kh Medtech Sarl	Composition injectable sterile contenant de l'acide hyaluronique reticule et de l'articaine
KR101944008B1 (ko) *	2017-09-18	2019-01-30	(주) 제이씨바이오	히알루론산을 포함하는 투명 하이드로겔 막 및 이를 이용한 콘택트렌즈
FR3072026B1 (fr) *	2017-10-10	2019-10-25	Capsum	Ensembles de particules, procedes de preparation et kits les comprenant
US11884765B2 (en)	2018-04-04	2024-01-30	Board Of Regents, The University Of Texas System	Biodegradable elastic hydrogels for bioprinting
JP7248967B2 (ja) *	2018-04-23	2023-03-30	国立大学法人北海道大学	ハイドロゲル及びハイドロゲルの製造方法
WO2020095079A1 (fr) *	2018-11-06	2020-05-14	Kylane Laboratoires Sa	Composition injectable contenant de l'acide hyaluronique pour des applications au niveau du corps
LU101045B1 (en)	2018-12-11	2020-06-11	Qventis GmbH	Method for the manufacture and use of a bionic hydrogel composition for medical applications
FR3095206B1 (fr)	2019-04-17	2021-11-05	Lab Vivacy	Procede de reticulation d’un polymere
CN111249172A (zh) *	2020-01-15	2020-06-09	陈勇	一种美容注射凝胶及其制备方法
EP3854377A1 (fr) *	2020-01-22	2021-07-28	Laboratoires Genevrier Sas	Composition comprenant de l'acide hyaluronique et un polyol ou de carboxyméthylcellulose
US20230172968A1 (en) *	2020-04-17	2023-06-08	Prohibix Llc	Controlled release hyaluronic acid compositions
FR3111903B1 (fr)	2020-06-24	2022-12-02	Lab Vivacy	Procede d’incorporation de composes organiques en solution au sein d’un hydrogel
US20230321319A1 (en) *	2020-08-18	2023-10-12	Innate S.R.L.	Injectable composition and use of said composition
FR3113522B1 (fr)	2020-08-20	2025-04-18	Lab Vivacy	procédé d’évaluation des caractéristiques rhéologiques d’un gel
WO2023064618A1 (en) *	2021-10-15	2023-04-20	Prohibix Llc	Crosslinked hyaluronic acid precipitates
FR3130132B1 (fr)	2021-12-09	2023-11-17	Oreal	Dispersion comprenant une particule polymerique, un agent stabilisant a groupe cycloalkyle, une huile, et de l’eau, procede de traitement des matieres keratiniques mettant en œuvre la dispersion
US20230190613A1 (en)	2021-12-09	2023-06-22	L'oreal	Skin perfecting cosmetic compositions and methods of use
FR3130131B1 (fr)	2021-12-09	2023-11-17	Oreal	Dispersion comprenant une particule polymerique, un agent stabilisant a groupe cycloalkyle, une huile, et un polyol, procede de traitement des matieres keratiniques mettant en œuvre la dispersion
FR3132220B1 (fr)	2022-01-31	2024-02-02	Oreal	compositions cosmétiques perfectrices de peau et procédés d’utilisation
FR3135399B1 (fr)	2022-03-30	2025-03-28	Lab Vivacy	émulsion comprenant un hydrogel et de la graisse ou un dérivé de graisse
CN116444826A (zh) *	2023-06-05	2023-07-18	天新福（北京）医疗器材股份有限公司	一种交联改性胶原蛋白凝胶、其制备方法和凝胶产品
WO2025063708A1 (ko) *	2023-09-20	2025-03-27	에이치엘비제약 주식회사	가교 히알루론산 하이드로겔과 세포외기질을 포함하는 주사용 조성물, 이의 제조방법 및 용도
FR3162003A1 (fr)	2024-05-12	2025-11-14	Laboratoires Vivacy	Composition de biomateriau comprenant un polyhydroxybutyrate sous forme particulaire

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1238043A (en)	1983-12-15	1988-06-14	Endre A. Balazs	Water insoluble preparations of hyaluronic acid and processes therefor
SE442820B (sv) *	1984-06-08	1986-02-03	Pharmacia Ab	Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
US4582865A (en)	1984-12-06	1986-04-15	Biomatrix, Inc.	Cross-linked gels of hyaluronic acid and products containing such gels
US5143724A (en)	1990-07-09	1992-09-01	Biomatrix, Inc.	Biocompatible viscoelastic gel slurries, their preparation and use
IT1260154B (it) *	1992-07-03	1996-03-28	Lanfranco Callegaro	Acido ialuronico e suoi derivati in polimeri interpenetranti (ipn)
FR2733426B1 (fr)	1995-04-25	1997-07-18	Debacker Yves	Dispositif medical pour le comblement des deformations du volume de la peau telles que rides et cicatrices par injection de 2 formes physico-chimiques differentes d'un polymere biologique
FR2733427B1 (fr) *	1995-04-25	2001-05-25	W K Et Associes	Compositions biphasiques injectables renfermant de l'acide hyaluronique, notamment utiles en chirurgies reparatrice et esthetique
JP3538741B2 (ja) *	1995-05-23	2004-06-14	独立行政法人科学技術振興機構	複合刺激応答型生体内分解性高分子ヒドロゲル
US6224893B1 (en)	1997-04-11	2001-05-01	Massachusetts Institute Of Technology	Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
JP4247846B2 (ja)	1997-07-03	2009-04-02	デュピュイ・スパイン・インコーポレーテッド	架橋ポリサッカリド薬物キャリア
FR2780730B1 (fr) *	1998-07-01	2000-10-13	Corneal Ind	Compositions biphasiques injectables, notamment utiles en chirurgies reparatrice et esthetique
GB9902412D0 (en)	1999-02-03	1999-03-24	Fermentech Med Ltd	Process
FR2811996B1 (fr) *	2000-07-19	2003-08-08	Corneal Ind	Reticulation de polysaccharide(s), preparation d'hydrogel(s) ; polysaccharide(s) et hydrogel(s) obtenus,leurs utilisations
AU2002309026A1 (en) *	2002-05-01	2003-11-17	Hokkaido Technology Licensing Office Co., Ltd.	Gel having multiple network structure and method for preparation thereof
US7334043B2 (en) *	2002-09-17	2008-02-19	At&T Delaware Intellectual Property, Inc.	Extending functionality of workflow applications using instant messaging (IM)
FR2861734B1 (fr)	2003-04-10	2006-04-14	Corneal Ind	Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
GB0329907D0 (en) *	2003-12-23	2004-01-28	Innomed Ltd	Compositions
FR2865737B1 (fr) *	2004-02-03	2006-03-31	Anteis Sa	Gel reticule biocompatible
US8293890B2 (en) *	2004-04-30	2012-10-23	Advanced Cardiovascular Systems, Inc.	Hyaluronic acid based copolymers
EP1750769B1 (en) *	2004-05-20	2013-01-23	Mentor Worldwide LLC	Methods for making injectable polymer hydrogels
US8025696B2 (en)	2004-06-18	2011-09-27	National University Corporation Hokkaido University	Artificial meniscus and process of making thereof
JP2006013612A (ja) *	2004-06-22	2006-01-12	Traffic Shimu:Kk	データ監視システム、プログラム、記録媒体、表示操作方法
US20060105022A1 (en) *	2004-11-15	2006-05-18	Shiseido Co., Ltd.	Process for preparing crosslinked hyaluronic acid gel
CN1302050C (zh) *	2005-07-07	2007-02-28	复旦大学	一种互穿网络聚合物超多孔水凝胶及其制备方法和应用
JP2009507110A (ja) *	2005-09-09	2009-02-19	オタワヘルスリサーチインスティテュート	相互侵入ネットワーク、およびそれに関連する方法および組成物
ES2747978T3 (es) *	2005-10-03	2020-03-12	Mark A Pinsky	Liposomas no fosfolipídicos que comprenden ácido hialurónico

2007
- 2007-12-07 FR FR0759641A patent/FR2924615B1/fr not_active Expired - Fee Related
2008
- 2008-12-08 EP EP12196144.5A patent/EP2572702B1/fr active Active
- 2008-12-08 ES ES08858227.5T patent/ES2538999T3/es active Active
- 2008-12-08 EA EA201070696A patent/EA022478B1/ru not_active IP Right Cessation
- 2008-12-08 AU AU2008333132A patent/AU2008333132B2/en active Active
- 2008-12-08 MX MX2010006248A patent/MX2010006248A/es active IP Right Grant
- 2008-12-08 PL PL08858227T patent/PL2231108T3/pl unknown
- 2008-12-08 PL PL12196144T patent/PL2572702T3/pl unknown
- 2008-12-08 US US12/746,639 patent/US20100303873A1/en not_active Abandoned
- 2008-12-08 PT PT88582275T patent/PT2231108E/pt unknown
- 2008-12-08 CA CA2708023A patent/CA2708023C/fr active Active
- 2008-12-08 KR KR1020107014771A patent/KR101597333B1/ko active Active
- 2008-12-08 BR BRPI0821046A patent/BRPI0821046B1/pt active IP Right Grant
- 2008-12-08 PT PT121961445T patent/PT2572702E/pt unknown
- 2008-12-08 WO PCT/EP2008/067029 patent/WO2009071697A1/fr not_active Ceased
- 2008-12-08 JP JP2010536490A patent/JP5571562B2/ja active Active
- 2008-12-08 UA UAA201008468A patent/UA99161C2/ru unknown
- 2008-12-08 EP EP08858227.5A patent/EP2231108B1/fr active Active
- 2008-12-08 ES ES12196144.5T patent/ES2526081T3/es active Active
- 2008-12-08 CN CN2008801256588A patent/CN101925348B/zh active Active
2010
- 2010-06-03 IL IL206166A patent/IL206166A/en active IP Right Grant
2014
- 2014-01-27 US US14/164,592 patent/US9919076B2/en active Active
- 2014-06-25 JP JP2014130602A patent/JP5883076B2/ja active Active
2017
- 2017-11-14 US US15/812,588 patent/US10207024B2/en active Active
2019
- 2019-01-16 US US16/249,606 patent/US20190167844A1/en not_active Abandoned
2021
- 2021-06-30 US US17/364,081 patent/US20210322636A1/en not_active Abandoned
2024
- 2024-06-20 US US18/748,968 patent/US20240335587A1/en active Pending

Also Published As

Publication number	Publication date
US9919076B2 (en)	2018-03-20
EA022478B1 (ru)	2016-01-29
EP2572702B1 (fr)	2014-10-08
FR2924615A1 (fr)	2009-06-12
JP2014184331A (ja)	2014-10-02
US20180064846A1 (en)	2018-03-08
FR2924615B1 (fr)	2010-01-22
JP5883076B2 (ja)	2016-03-09
IL206166A (en)	2017-06-29
CN101925348B (zh)	2013-12-04
EP2231108A1 (fr)	2010-09-29
CN101925348A (zh)	2010-12-22
ES2526081T3 (es)	2015-01-05
EP2231108B1 (fr)	2015-04-01
US20190167844A1 (en)	2019-06-06
BRPI0821046B1 (pt)	2017-04-04
WO2009071697A1 (fr)	2009-06-11
US20240335587A1 (en)	2024-10-10
HK1150772A1 (en)	2012-01-13
US20210322636A1 (en)	2021-10-21
EP2572702A1 (fr)	2013-03-27
CA2708023C (fr)	2017-10-03
EA201070696A1 (ru)	2010-12-30
UA99161C2 (en)	2012-07-25
KR20100118102A (ko)	2010-11-04
US10207024B2 (en)	2019-02-19
PL2572702T3 (pl)	2015-03-31
MX2010006248A (es)	2010-10-20
AU2008333132A1 (en)	2009-06-11
US20140142190A1 (en)	2014-05-22
AU2008333132B2 (en)	2013-06-06
PL2231108T3 (pl)	2015-09-30
KR101597333B1 (ko)	2016-02-24
CA2708023A1 (fr)	2009-06-11
JP2011505883A (ja)	2011-03-03
ES2538999T3 (es)	2015-06-25
PT2231108E (pt)	2015-07-07
IL206166A0 (en)	2010-12-30
JP5571562B2 (ja)	2014-08-13
PT2572702E (pt)	2015-01-02
US20100303873A1 (en)	2010-12-02

Publication	Publication Date	Title
BRPI0821046A2 (pt)	2015-09-22	hidrogel coesivo monofásico biodegradável, processo de preparação do mesmo, utilização de um hidrogel, e, kit
BRPI0915134A2 (pt)	2016-02-16	composto, e, uso de um composto
BRPI0917579A2 (pt)	2016-10-11	composto, composição farmacêutica, métodos, e, uso de um composto
BRPI0906186A2 (pt)	2015-09-22	composto e uso de um composto
EP2195039A4 (en)	2013-01-09	SURGICAL HYDROGEL
BRPI0908252A2 (pt)	2015-07-21	Processo para preparar um composto, e, uso de um composto
BRPI0821801A2 (pt)	2015-07-14	Zeólito e processo de preparação de um zeólito.
BRPI0720083A2 (pt)	2014-01-21	Adesivo e hidrogel de biopolímero imidado
IL202866A (en)	2014-01-30	Analysis kits
BRPI0818223A2 (pt)	2015-09-08	preservativo com revestimento multifuncional
BRPI0919216A2 (pt)	2015-12-08	poliuretano, e, uso de um poliuretano
BRPI0812146A2 (pt)	2014-11-18	Processo, mistura, utilização da mistura, borracha sintética
BRPI0913188A2 (pt)	2016-01-12	moduladores de receptores 5-ht3, métodos de fabricação, e uso dos mesmos
BRPI0918487A2 (pt)	2015-12-01	processo para a preparação de uma composição de copolímero, composição, e, uso de uma composição de copolímero
EP2080641A4 (en)	2010-06-02	Pneumatic radial tire
EP2140877A4 (en)	2010-04-21	NEW USE OF COCCIDIAN
BRPI0923919A2 (pt)	2016-01-12	dessulfurizar adsorvente, processo de preparação e uso do mesmo
BRPI0914013A2 (pt)	2015-10-27	"dispositivo de retração dentária, kit de partes, processo de fabricação de um dispositivo de retração dentária".
BRPI0813438A2 (pt)	2014-12-23	Processo para preparar um composto, uso de um composto, e, composto.
EP2139030A4 (en)	2011-03-23	etching
FR2914165B3 (fr)	2009-02-27	Couffin protatif de forme ovoide
BRPI0814631A2 (pt)	2015-07-14	Adesivo, método para aderir tecido biológico, kit, e artigo.
EP2051987A4 (en)	2011-08-03	USE OF CB83 IN COMBINATION THERAPIES
BRPI0906978A2 (pt)	2015-07-14	Composição, processos de preparação de uma composição e de um dispositivo combinado com medicamento, dispositivo combinado com medicamento, kit e uso de uma composição
BR112012002087A2 (pt)	2015-09-01	Grânulos, processo para a preparação dos grânulos e uso dos grânulos

Legal Events

Date	Code	Title
2016-03-08	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2017-02-07	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2017-04-04	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
2018-05-02	B25G	Requested change of headquarter approved
2018-05-08	B25G	Requested change of headquarter approved
2018-05-22	B25L	Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled